Carregando...
Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy
Cancer immunotherapy with checkpoint blockade has become standard of care treatment for numerous cancer types. Despite this, robust predictive biomarkers are lacking. There is increasing evidence that the host microbiome is a predictor of immunotherapy response, although the optimal host microbiome...
Na minha lista:
| Publicado no: | J Immunother Cancer |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604862/ https://ncbi.nlm.nih.gov/pubmed/33127655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001383 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|